Vaccines
High-Throughput Testing
Accelerating Vaccine Development Process and Scale
IQVIA Laboratories Vaccines utilizes automated systems for high throughput through our investment in robotics to support our scientists, who generate over 1.5 million results annually. Our immense capacity helps accelerate the vaccine discovery and clinical trial process. Controlling for variability when performing manual processes at the order of magnitude required for large sample volume throughput is virtually impossible. However, our investment in automation helps our team to deliver consistently with accuracy, reproducibility, and precision to meet client’s expectations and timelines. Our automated, validated data reporting systems also ensure objectivity when generating results. With state-of-the-art equipment at our facilities globally, our team produces data for large scale projects with increased output for consistent and timely delivery of results.
High-Throughput Automation Robotics
IQVIA Laboratories Vaccines has invested in state-of-the-art automation platforms that allow in-house High Throughput Screening (HTS). With robotics to support our specialty lab testing platforms, our laboratories are integrated with industry leading turnkey solutions ranging from assay set up and execution to sample storage, including automated labeling. Robotic workstations have several advantages over manual processes as robots can work continuously to increase the throughput, perform consistently, and ensure accuracy and precision. With our ability to quickly scale up operations, our teams are well-equipped to meet market demands without compromising the flexibility and agility we are known for.
Our robotic systems help to streamline the workflow of your projects and optimize laboratory capacity by maximizing how we utilize our bench space. Automation provides greater efficiency and reproducibility of assays without compromising the quality of our data. In addition to the ability to provide efficient and reliable results, the process (study set up, timelines, etc.) and the performance efficiency of our technicians has markedly improved. Replacing manual, repetitive tasks with automation allows our experts to focus on solving the key problems for our clients.
Automated Liquid Handlers
Our automatic liquid handlers have increased our testing capacity, as compared to manual experiments, particularly for pipetting operations. We can perform sample preparation, dilution, and plating.
Equipment
- Integra AssistPlus
- Integra ViaFlow
- Integra ViaFill
Automated Image Analyzers
IQVIA Laboratories Vaccines has a wide range of automated image capture and analysis systems to support viral and bacterial functional assays for the determination of plaque-forming-units (PFU) or colony-forming-units (CFU).
InDevR CipherOne
- Image analysis system
- Automated hemagglutination (HA) and hemagglutination inhibition (HAI) interpretation instrument.
BioTek Cytation 7 Linked to Robotic Arm
- Cell imaging system with multiple reader modes combines an upright and inverted microscope and multimode multiplate detection.
Custom Validated Template for Data Capture and Analysis
Our data generation and repository include programing and validation using Excel and SoftMax Pro software. These validated workbooks simplify your data acquisition and report workflows. Raw data can be imported directly from any of our assay instruments without loss of integrity, simplifying data acquisition and report workflow. Our integrated data analytics service also includes a convenient specialized calculation worksheet. Using input data collected from the assay instrument, the workbook will calculate the concentration of the analyte and report whether the concentration is reliable based on the standard curve. All data results generated within these templates sync automatically to our LIMS system.
Explore more
- Assay Catalog
- Assay Development and Technology Transfer
- Early Development Assays
- Immunotherapy
- Preclinical Assay Development and In Vivo Services
- Translational Sciences
- Laboratory Locations
- Scientists and Experts
- Infectious Disease
- Leading the Way to Develop Reference Assays for COVID-19 Vaccines
- Assays for Vaccine Development and Testing